Downregulation of immunological mediators in 2,4-dinitrofluorobenzene-induced atopic dermatitis-like skin lesions by hydrocortisoneloaded chitosan nanoparticles
Background: Atopic dermatitis is a chronic, noncontiguous, and exudative disorder accompanied by perivascular infiltration of immune mediators, including T-helper (Type 1 helper/Type 2 helper) cells, mast cells, and immunoglobulin E. The current study explores the immunomodulatory and histological e...
Published in: | International Journal of Nanomedicine |
---|---|
Main Author: | |
Format: | Article |
Language: | English |
Published: |
Dove Medical Press Ltd.
2014
|
Online Access: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-84908519237&doi=10.2147%2fIJN.S71543&partnerID=40&md5=5c5d19b030efb834ad52da46a75ec71d |
id |
2-s2.0-84908519237 |
---|---|
spelling |
2-s2.0-84908519237 Hussain Z.; Katas H.; Amin M.C.I.M.; Kumolosasi E.; Sahudin S. Downregulation of immunological mediators in 2,4-dinitrofluorobenzene-induced atopic dermatitis-like skin lesions by hydrocortisoneloaded chitosan nanoparticles 2014 International Journal of Nanomedicine 9 1 10.2147/IJN.S71543 https://www.scopus.com/inward/record.uri?eid=2-s2.0-84908519237&doi=10.2147%2fIJN.S71543&partnerID=40&md5=5c5d19b030efb834ad52da46a75ec71d Background: Atopic dermatitis is a chronic, noncontiguous, and exudative disorder accompanied by perivascular infiltration of immune mediators, including T-helper (Type 1 helper/Type 2 helper) cells, mast cells, and immunoglobulin E. The current study explores the immunomodulatory and histological effects of nanoparticle (NP)-based transcutaneous delivery of hydrocortisone (HC).; Methods: In this study, HC, the least potent topical glucocorticoid, was administered transcutaneously as chitosan NPs. The pharmacological and immunological effects of the NP-based HC delivery on the alleviation of 2, 4-dinitrofluorobenzene-induced atopic dermatitis (AD)-like skin lesions were evaluated using the NC/Nga mouse model.; Results: In vivo Dino-Lite® microscopic assessment revealed that the NP-based formulation displayed a remarkable ability to reduce the severity of the pathological features of AD (dermatitis index, 3.0). The AD suppressive activity of the NP-based topical formulation was expected owing to the interruption of a series of immunopathological events, including the production of immunoglobulin E, release of histamine, and expression of prostaglandin-E2 and vascular endothelial growth factor-α in the sera and skin of the tested animals. Analysis of the cytokine expression in AD-like skin lesions further revealed that the NP-based formulation inhibited the pathological expression of interleukin (IL)-4, IL-5, IL-6, IL-13, IL-12p70, interferon-γ, and tumor necrosis factor-α in serum and skin homogenates of NC/Nga mice. Further, our histological findings indicated that the NP-based formulation inhibited fibroblast infiltration and fragmentation of elastic fibers, further supporting the clinical importance of these formulations in maintaining the integrity of elastic connective tissues.; Conclusion: The current investigation suggests that NP-mediated transcutaneous delivery of HC could be considered an effective therapeutic approach to manage dermatitis. © 2014 Hussain et al. Dove Medical Press Ltd. 11769114 English Article All Open Access; Gold Open Access; Green Open Access |
author |
Hussain Z.; Katas H.; Amin M.C.I.M.; Kumolosasi E.; Sahudin S. |
spellingShingle |
Hussain Z.; Katas H.; Amin M.C.I.M.; Kumolosasi E.; Sahudin S. Downregulation of immunological mediators in 2,4-dinitrofluorobenzene-induced atopic dermatitis-like skin lesions by hydrocortisoneloaded chitosan nanoparticles |
author_facet |
Hussain Z.; Katas H.; Amin M.C.I.M.; Kumolosasi E.; Sahudin S. |
author_sort |
Hussain Z.; Katas H.; Amin M.C.I.M.; Kumolosasi E.; Sahudin S. |
title |
Downregulation of immunological mediators in 2,4-dinitrofluorobenzene-induced atopic dermatitis-like skin lesions by hydrocortisoneloaded chitosan nanoparticles |
title_short |
Downregulation of immunological mediators in 2,4-dinitrofluorobenzene-induced atopic dermatitis-like skin lesions by hydrocortisoneloaded chitosan nanoparticles |
title_full |
Downregulation of immunological mediators in 2,4-dinitrofluorobenzene-induced atopic dermatitis-like skin lesions by hydrocortisoneloaded chitosan nanoparticles |
title_fullStr |
Downregulation of immunological mediators in 2,4-dinitrofluorobenzene-induced atopic dermatitis-like skin lesions by hydrocortisoneloaded chitosan nanoparticles |
title_full_unstemmed |
Downregulation of immunological mediators in 2,4-dinitrofluorobenzene-induced atopic dermatitis-like skin lesions by hydrocortisoneloaded chitosan nanoparticles |
title_sort |
Downregulation of immunological mediators in 2,4-dinitrofluorobenzene-induced atopic dermatitis-like skin lesions by hydrocortisoneloaded chitosan nanoparticles |
publishDate |
2014 |
container_title |
International Journal of Nanomedicine |
container_volume |
9 |
container_issue |
1 |
doi_str_mv |
10.2147/IJN.S71543 |
url |
https://www.scopus.com/inward/record.uri?eid=2-s2.0-84908519237&doi=10.2147%2fIJN.S71543&partnerID=40&md5=5c5d19b030efb834ad52da46a75ec71d |
description |
Background: Atopic dermatitis is a chronic, noncontiguous, and exudative disorder accompanied by perivascular infiltration of immune mediators, including T-helper (Type 1 helper/Type 2 helper) cells, mast cells, and immunoglobulin E. The current study explores the immunomodulatory and histological effects of nanoparticle (NP)-based transcutaneous delivery of hydrocortisone (HC).; Methods: In this study, HC, the least potent topical glucocorticoid, was administered transcutaneously as chitosan NPs. The pharmacological and immunological effects of the NP-based HC delivery on the alleviation of 2, 4-dinitrofluorobenzene-induced atopic dermatitis (AD)-like skin lesions were evaluated using the NC/Nga mouse model.; Results: In vivo Dino-Lite® microscopic assessment revealed that the NP-based formulation displayed a remarkable ability to reduce the severity of the pathological features of AD (dermatitis index, 3.0). The AD suppressive activity of the NP-based topical formulation was expected owing to the interruption of a series of immunopathological events, including the production of immunoglobulin E, release of histamine, and expression of prostaglandin-E2 and vascular endothelial growth factor-α in the sera and skin of the tested animals. Analysis of the cytokine expression in AD-like skin lesions further revealed that the NP-based formulation inhibited the pathological expression of interleukin (IL)-4, IL-5, IL-6, IL-13, IL-12p70, interferon-γ, and tumor necrosis factor-α in serum and skin homogenates of NC/Nga mice. Further, our histological findings indicated that the NP-based formulation inhibited fibroblast infiltration and fragmentation of elastic fibers, further supporting the clinical importance of these formulations in maintaining the integrity of elastic connective tissues.; Conclusion: The current investigation suggests that NP-mediated transcutaneous delivery of HC could be considered an effective therapeutic approach to manage dermatitis. © 2014 Hussain et al. |
publisher |
Dove Medical Press Ltd. |
issn |
11769114 |
language |
English |
format |
Article |
accesstype |
All Open Access; Gold Open Access; Green Open Access |
record_format |
scopus |
collection |
Scopus |
_version_ |
1809677609412329472 |